Home/ Supplements/ Vitamin K/ Vitamin K2 MK-7 60 mcg

Vitamin K2 MK-7 60 mcg

product on market Capsule ProCaps Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin K2 MK-7 is supported by moderate evidence for promoting calcium deposition in bones and preventing arterial calcification. Research indicates it works synergistically with Vitamin D to regulate calcium metabolism. The current evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Vitamin K2 MK-7 60 mcg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
360
Servings
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

60 mcg
Within RDA (0.5× RDA) 275 studies (A:9, B:175)

Other Ingredients

Extra Virgin Olive Oil Gelatin Water, Purified Glycerin
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use Consume one capsule daily. You can increase your intake as required or as guided by your physician.

Formulation Notes

Since 1979, Unsurpassed purity, quality and efficacy. 100% solar production Zero carbon footprint 100% solar

Vitamin K's most beneficial form

Promotes optimum heart + bone + circulatory health

Andrew Lessman's Vitamin K2 MK-7 60 provides the most beneficial form of vitamin K in the form of vitamin K2 menaquinone-7 (K2 MK-7). Vitamin K2 MK-7 is now recognized as essential for bone and heart health through its role in regulating calcium metabolism. Unlike typical vitamin K1 and its role in blood clotting, vitamin K2 MK-7 is unique given its essential role in calcium utilization and thus bone, heart and circulatory health. Essentially, K2 MK-7 promotes the retention of calcium in healthy bone while inhibiting undesirable calcification in tissues such as arteries, heart valves, etc. By reducing calcification, K2 MK-7 promotes flexible, resilient arteries and heart valves - a defining characteristic of cardiovascular health. In short, K2 MK-7 help our body retain calcium where required (our bones) and reduce deposits where calcification is to be avoided. Unfortunately, there is no meaningful source of K2 MK-7 in the American diet, so achieving these desirable heart and bone health benefits requires supplementation of this essential vitamin.

Contains no additives or common allergens Contains no milk, soy, yeast, corn, wheat, gluten, sodium, salt, sugar, cholesterol, color, preservative, common allergens, genetically modified (GMO) ingredients or manufacturing additives.

Additional Information

For questions about the use of this product call 800.800.1200. Andrew Lessman, Founder Questions? Reorders? 800.800.1200 www.Procapslabs.com Andrew Lessman

Metadata

Product Details

UPC / SKU743387
DSLD Entry Date2025-05-21
Product TypeVitamin
FormCapsule
BrandProCaps
DSLD ID331626
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.